CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques
Sign Up to like & getrecommendations! Published in 2019 at "Nature Communications"
DOI: 10.1038/s41467-019-09725-6
Abstract: A major barrier to human immunodeficiency virus (HIV) cure is the existence of viral reservoirs that lead to viral rebound following discontinuation of antiretroviral therapy (ART). We postulate that enhancing cytotoxic T lymphocytes (CTL) targeting… read more here.
Keywords: viral rebound; rebound art; art free; shiv ... See more keywords